Literature DB >> 9914607

Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?

D Abramovici1, S A Friedman, B M Mercer, F Audibert, L Kao, B M Sibai.   

Abstract

OBJECTIVE: Our purpose was to compare neonatal outcome after preterm delivery of infants whose gestation was complicated by the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, partial HELLP syndrome, or severe preeclampsia. STUDY
DESIGN: We reviewed the maternal and neonatal charts from 269 consecutive pregnancies complicated by the HELLP syndrome or severe preeclampsia managed at our perinatal center. The HELLP syndrome was defined by previously published laboratory criteria. Viable pregnancies were divided into 3 groups: HELLP syndrome, partial HELLP syndrome (at least 1, but not all 3, features of the HELLP syndrome), and severe preeclampsia (no features of the HELLP syndrome). Results were compared by means of chi2 analysis and Student t test where appropriate. Logistic regression was used to evaluate outcome variables at different gestational ages.
RESULTS: There were no significant differences in complications among the 3 groups at each gestational age. There was, as expected, a significant decrease in morbidity and mortality rates with advanced gestational age.
CONCLUSIONS: In severe preeclampsia, neonatal morbidity and death are related to gestational age rather than to the presence or absence of the HELLP syndrome. Whether expectant management is safe for women with the HELLP syndrome requires further study.

Entities:  

Mesh:

Year:  1999        PMID: 9914607     DOI: 10.1016/s0002-9378(99)70178-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

Review 1.  Hypertension in pregnancy.

Authors:  Maryann Mugo; Gurushankar Govindarajan; L Romayne Kurukulasuriya; James R Sowers; Samy I McFarlane
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 2.  Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management.

Authors:  Prem S Shekhawat; Dietrich Matern; Arnold W Strauss
Journal:  Pediatr Res       Date:  2005-04-06       Impact factor: 3.756

3.  Comparison of maternal and neonatal outcomes in women with HELLP syndrome and women with severe preeclampsia without HELLP syndrome.

Authors:  Abdulkadir Turgut; Oya Demirci; Elif Demirci; Mehmet Uludoğan
Journal:  J Prenat Med       Date:  2010-07

4.  Laboratory abnormalities in pregnancy-associated hypertension: frequency and association with pregnancy outcomes.

Authors:  Jessica Cantu; Rebecca G Clifton; James M Roberts; Kenneth J Leveno; Leslie Myatt; Uma M Reddy; Michael W Varner; Ronald J Wapner; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Philip Samuels; Anthony Sciscione; George Saade; Yoram Sorokin
Journal:  Obstet Gynecol       Date:  2014-11       Impact factor: 7.661

5.  Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Heather A Drummond; Babbette LaMarca; Michael J Ryan; Joey P Granger
Journal:  Compr Physiol       Date:  2020-12-09       Impact factor: 9.090

Review 6.  Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy.

Authors:  Douglas M Woudstra; Sue Chandra; G Justus Hofmeyr; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

7.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

8.  Neonatal outcome after preterm delivery in HELLP syndrome.

Authors:  Hye Yeon Kim; Yong Seok Sohn; Jae Hak Lim; Euy Hyuk Kim; Ja Young Kwon; Yong Won Park; Young Han Kim
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

9.  Severe Preeclampsia versus HELLP Syndrome: Maternal and Perinatal Outcomes at <34 and ≥34 Weeks' Gestation.

Authors:  Tuğba Kınay; Canan Küçük; Fulya Kayıkçıoğlu; Jale Karakaya
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

10.  First-trimester maternal serum PP13 in the risk assessment for preeclampsia.

Authors:  Roberto Romero; Juan Pedro Kusanovic; Nandor Gabor Than; Offer Erez; Francesca Gotsch; Jimmy Espinoza; Samuel Edwin; Ilana Chefetz; Ricardo Gomez; Jyh Kae Nien; Marei Sammar; Beth Pineles; Sonia S Hassan; Hamutal Meiri; Yossi Tal; Ido Kuhnreich; Zoltan Papp; Howard S Cuckle
Journal:  Am J Obstet Gynecol       Date:  2008-06-09       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.